Access cutting-edge small bowel cancer treatment through this clinical trial at a research site in Kingman. Study-provided care at no cost to qualified participants.
Access small bowel cancer specialists in Kingman at no cost
This study follows strict safety protocols and ethical guidelines
All study-related small bowel cancer treatment provided free
This phase II trial studies how well ramucirumab and paclitaxel or the FOLFIRI regimen (leucovorin calcium, fluorouracil, and irinotecan hydrochloride) work in treating patients with small bowel cancers that have spread extensively to other anatomic sites (advanced) or are no longer responding to treatment (refractory). Ramucirumab is a monoclonal antibody that attaches to and inhibits a molecule called VEGFR-2. This may restrain new blood vessel formation therefore reducing nutrient supply to t
Sponsor: SWOG Cancer Research Network
Check if you qualify for this small bowel cancer clinical trial in Kingman, AZ
If you're searching for small bowel cancer treatment options in Kingman, AZ, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Kingman research site is actively enrolling participants for this clinical trial. You'll receive care from experienced small bowel cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.